Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $855K | ﹤0.01% |
60,700
-6,400
| -10% | -$90.1K |
|
2377
Scilex Holding
SCLX
$177M
| $853K | ﹤0.01% |
+4,377
| New | +$853K |
|
2378
Liquidity Services
LQDT
$845M
| $851K | ﹤0.01% |
51,600
-9,800
| -16% | -$162K |
|
2379
National Presto Industries
NPK
$784M
| $849K | ﹤0.01% |
11,600
+200
| +2% | +$14.6K |
|
2380
NETGEAR
NTGR
$823M
| $847K | ﹤0.01% |
59,800
-2,500
| -4% | -$35.4K |
|
2381
LoveSac
LOVE
$302M
| $846K | ﹤0.01% |
31,400
+1,900
| +6% | +$51.2K |
|
|
SKE
2382
Skeena Resources
SKE
$2.05B
| $844K | ﹤0.01% |
174,700
+33,300
| +24% | +$161K |
|
|
ICPT
2383
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $841K | ﹤0.01% |
76,000
| – | – |
|
2384
Centrus Energy
LEU
$3.99B
| $840K | ﹤0.01% |
25,800
+1,900
| +8% | +$61.9K |
|
2385
RAPT Therapeutics
RAPT
$234M
| $838K | ﹤0.01% |
5,600
-2,188
| -28% | -$327K |
|
2386
Luxfer Holdings
LXFR
$358M
| $837K | ﹤0.01% |
58,800
| – | – |
|
2387
Preformed Line Products
PLPC
$953M
| $836K | ﹤0.01% |
+5,353
| New | +$836K |
|
2388
Shoe Carnival
SCVL
$653M
| $834K | ﹤0.01% |
35,500
-3,200
| -8% | -$75.1K |
|
2389
HarborOne Bancorp
HONE
$551M
| $829K | ﹤0.01% |
95,484
| – | – |
|
2390
OraSure Technologies
OSUR
$238M
| $828K | ﹤0.01% |
165,300
+16,400
| +11% | +$82.2K |
|
|
WW
2391
DELISTED
WW International
WW
| $826K | ﹤0.01% |
+122,900
| New | +$826K |
|
2392
iHeartMedia
IHRT
$323M
| $820K | ﹤0.01% |
225,400
-24,200
| -10% | -$88.1K |
|
2393
Anika Therapeutics
ANIK
$121M
| $818K | ﹤0.01% |
31,500
| – | – |
|
2394
Cricut
CRCT
$1.33B
| $816K | ﹤0.01% |
66,900
+10,400
| +18% | +$127K |
|
2395
Republic Bancorp
RBCAA
$1.49B
| $816K | ﹤0.01% |
19,200
-1,700
| -8% | -$72.3K |
|
2396
Alector
ALEC
$287M
| $815K | ﹤0.01% |
135,600
+19,600
| +17% | +$118K |
|
2397
Fate Therapeutics
FATE
$115M
| $814K | ﹤0.01% |
171,000
+3,200
| +2% | +$15.2K |
|
2398
Montauk Renewables
MNTK
$290M
| $814K | ﹤0.01% |
109,400
-30,000
| -22% | -$223K |
|
2399
Lindblad Expeditions
LIND
$717M
| $811K | ﹤0.01% |
74,541
| – | – |
|
2400
HCI Group
HCI
$2.31B
| $809K | ﹤0.01% |
13,100
-3,000
| -19% | -$185K |
|